Director of Industry and Innovation, Wessex AHSN
After a PhD in genetics Frank moved into commercial research. After time in Syngenta, Pfizer and Boehringer-Ingelheim Frank joined Wessex AHSN in 2015. His commercial experience spans all stages from lab research and IP to major global products.
Frank is now Director of Industry and Innovation for Wessex AHSN, leading on delivery of the Economic Growth commission.